Judge Tells Abbott to Supply CEO’s E-mails Related to Federal Probe

A federal judge ordered pharmaceutical company Abbott Laboratories to hand over e-mails from its chief executive as part of an investigation into potential unlawful marketing of Abbott’s antiseizure drug, Depakote. From the Wall Street Journal:

The U.S. Attorney’s Office for the Western District of Virginia is investigating Abbott for “potential federal violations arising out of Abbott’s impermissible off-label marketing of Depakote as a treatment for agitation and aggression in the elderly, and health-care fraud arising out of that allegedly improper use,” U.S. District Judge Samuel Wilson wrote in an opinion dated March 10.

Depakote is approved by the U.S. Food and Drug Administration to treat seizure disorders and acute manic episodes associated with bipolar disorder, and to prevent migraine headaches, but not for treatment of agitation and aggression in the elderly.

Print Print  

Like what we're doing? We'd appreciate your support.

Leave a comment